303 results on '"Miglio, Gianluca"'
Search Results
2. Impact of the COVID-19 Pandemic on the Use of Antidepressants by Young Adults in the ASL TO4 Regione Piemonte (Italy)
3. Analysis of fumarate-sensitive proteins and sites by exploiting residue interaction networks
4. Clinical decision support systems to improve drug prescription and therapy optimisation in clinical practice: a scoping review
5. A computational analysis of S-(2-succino)cysteine sites in proteins
6. Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy)
7. Clinical decision support systems to improve drug prescription and therapy optimisation in clinical practice: a scoping review
8. Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
9. Assessing Therapeutic Choices and Adherence to Antidiabetic Therapy in Naïve Patients: A Retrospective Observational Study in a Local Health Authority of the Piedmont Region (Italy).
10. G protein–coupled receptor 21 in macrophages: An in vitro study
11. GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells
12. PPARγ stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss
13. A network approach for the study of drug (co)prescriptions: analysis of data from the A.S.L. TO4 (Regione Piemonte, Italy)
14. Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes
15. A Network Approach for the Study of Drug Prescriptions: Analysis of Administrative Records from a Local Health Unit (ASL TO4, Regione Piemonte, Italy)
16. Targets of Dimethyl Fumarate: a Novel Predictive Method Based on Concepts of Network Theory and Machine Learning
17. Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patients
18. Protective effects of peroxisome proliferator-activated receptor agonists on human podocytes: proposed mechanisms of action
19. The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury
20. Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats
21. Sedentariness and Urinary Metabolite Profile in Type 2 Diabetic Patients, a Cross-Sectional Study
22. Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
23. Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes
24. Identification and biochemical characterization of the Anopheles gambiae 3-hydroxykynurenine transaminase
25. Stimulation of group I metabotropic glutamate receptors evokes calcium signals and c-jun and c-fos gene expression in human T cells
26. Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia
27. Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice
28. Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets
29. Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies
30. Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
31. Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl‐peptidase 4 inhibition
32. Histamine type 1-receptor activation by low dose of histamine undermines human glomerular slit diaphragm integrity
33. Linagliptin decreases the growth of immortalised human podocytes through the SDF-1-CXCR4/CXCR7 axis
34. EXPLORING THE AMYLOID BETA (ABETA) DEPENDENT METABOLIC FINGERPRINT OF HIPPOCAMPAL NEURONS BY TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY: POTENTIALS IN DRUG DISCOVERY STUDIES
35. Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs?
36. Use of the Morita-Baylis-Hillman reaction in the design of compounds inhibiting NLRP3 inflammasome signaling pathways
37. The Mode of Action of Dimethyl Fumarate: Protein Succination and Anti-Pyroptotic Effects
38. Design and synthesis of N‐benzoyl amino acid derivatives as DNA methylation inhibitors
39. Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
40. I corticosteroidi per diminuire la mortalità dei pazienti con tubercolosi: una revisione sistematica e metanalisi
41. Due trial randomizzati sul canakinumaba nell’artrite idiopatica giovanile (juvenile idiopathic arthritis; JIA) sistemica
42. Lo status cardiaco dei bambini infettati da HIV che hanno ricevuto terapia antiretrovirale di associazione per lungo tempo: i risultati dall’Adolescent Master Protocol (AMP) of the Multicenter Pediatric HIV/AIDS Cohort Study
43. I nuovi trattamenti per l’asma severo e resistente: verso la terapia personalizzata
44. Analisi della cost-utility del deferiprone per il trattamento dei pazienti con β-talassemia e accumulo di ferro cronico
45. Esposizione prenatale al valproato e rischio di disturbo dello spettro autistico e di autismo infantile
46. Il vedolizumab come terapia d’induzione e di mantenimento della malattia di Crohn
47. L’immunosoppressione per la nefropatia membranosa progressiva: uno studio randomizzato e controllato condotto nel Regno Unito
48. Numerosità dei pazienti che hanno partecipato agli studi condotti prima dell’approvazione all’immissione in commercio dei nuovi farmaci: l’analisi di un database
49. Presente e futuro della terapia dell’infezione da Hepatitis C Virus (HCV)
50. Il riociguat per l’ipertensione polmonare
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.